Juan Barroso, MD
Adult Medicine · Hialeah, FLNPI 1699863118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,281, 8.4 times the $152 reported in 2019. Among adult medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$433
- AstraZeneca$386
- Novo Nordisk$374
- Amgen$346
- Sunovion Pharmaceuticals Inc.$261
- Esperion Therapeutics, Inc.$242
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,40798%
- Education$862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $433 |
| AstraZeneca | 19 | $386 |
| Novo Nordisk | 18 | $374 |
| Amgen | 22 | $346 |
| Sunovion Pharmaceuticals Inc. | 14 | $261 |
| Esperion Therapeutics, Inc. | 5 | $242 |
| Ardelyx, Inc. | 10 | $223 |
| AbbVie(2 entities) | 9 | $187 |
| Lilly USA, LLC | 9 | $174 |
| Johnson & Johnson | 8 | $145 |
| Pfizer | 8 | $143 |
| Sumitomo Pharma America, Inc. | 6 | $137 |
| Eisai Inc. | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| Lundbeck LLC | 4 | $114 |
| Madrigal Pharmaceuticals | 4 | $108 |
| Biogen | 6 | $107 |
| GSK | 5 | $102 |
| Novartis | 5 | $96 |
| Astellas Pharma US Inc | 5 | $84 |
| Xeris Pharmaceuticals, Inc. | 4 | $77 |
| Abbott | 4 | $73 |
| Boehringer Ingelheim | 4 | $69 |
| Edwards Lifesciences | 2 | $57 |
| Shield Therapeutics Inc | 1 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $40 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $25 |
| Exact Sciences | 1 | $23 |
| Radius Health, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Alvogen Inc | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Merck | 1 | $16 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,493 in reported general payments places this provider in the 90th percentile of 195 adult medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 384 | $184,599 |
| OzempicSemaglutide | 153 | $155,384 |
| FarxigaDapagliflozin Propanediol | 183 | $136,645 |
| RybelsusSemaglutide | 110 | $132,505 |
| LinzessLinaclotide | 192 | $126,388 |
| MounjaroTirzepatide | 103 | $109,041 |
| JardianceEmpagliflozin | 106 | $101,826 |
| JanuviaSitagliptin Phosphate | 91 | $100,273 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 113 | $76,037 |
| EntrestoSacubitril/Valsartan | 119 | $70,612 |
| MyrbetriqMirabegron | 109 | $65,080 |
| XareltoRivaroxaban | 104 | $56,269 |
| XifaxanRifaximin | 13 | $52,310 |
| GemtesaVibegron | 50 | $34,522 |
| ProliaDenosumab | 19 | $33,599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $374 | $287,889263 claims |
| PfizerEliquis | $143 | $184,599384 claims |
| AstraZenecaFarxiga, Symbicort, Brilinta, Byetta | $386 | $167,967257 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $69 | $140,621145 claims |
| AbbVieLinzess, Synthroid, Restasis | $187 | $139,484258 claims |
| Lilly USA, LLCMounjaro, Trulicity | $174 | $133,810117 claims |
| MerckJanuvia, Verquvo, Janumet | $16 | $113,736121 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $102 | $91,037150 claims |
| NovartisEntresto | $96 | $70,612119 claims |
| Astellas Pharma US IncMyrbetriq | $84 | $65,080109 claims |
| Johnson & JohnsonXarelto | $145 | $56,269104 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $433 | $52,31013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 195 adult medicine providers in Florida.
Other adult medicine in Hialeah
- Esperanza Arce NunezHialeah$2K
- Steven SantiagoMiami$290K
- Tammy DsouzaKissimmee$191K
- Eric SchertzerPlantation$26K
- Ricardo SerranoMerritt Island$20K
- Marlene JarinMiami Beach$18K
- Myra ReedPanama City Beach$16K
- Joshua RycusCoral Springs$13K
- Frederick WeigandDeltona$9K
- Hernando ChongMiami$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.